XenoTech Acquired by BioIVT
September 12, 2022
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, announced that it has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, ...
Keep Reading
